SCHEMBL1440611

SCHEMBL1440611

[CH2]C(C)COC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6966711 0.81 TDP1 (0.46)
SCHEMBL11618596 0.80 ALDH1A1 (0.50)
SCHEMBL3670007 0.79
Acetic Acid Isobutyl Ester SCHEMBL28489463 0.79 TSHR (0.60)
SCHEMBL2906354 0.79 TSHR (0.38)
Acetic Acid Isobutyl Ester SCHEMBL6360200 0.79 TSHR (0.60)
SCHEMBL6046949 0.78 TSHR (0.72)
Acetic Acid Isobutyl Ester SCHEMBL22678 0.78
SCHEMBL9756912 0.78 TDP1 (0.48)
SCHEMBL11644788 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832082-B1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ASTRAZENECA AB (SE) 2001-11-21 EP claimed
EP-0832082-A1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1998-04-01 EP claimed
WO-1996040681-A1 N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS ZENECA LIMITED (GB) 1996-12-19 WO claimed
WO-2008065408-A9 MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS HUNTER-FLEMING LIMITED (GB) 2011-03-03 WO disclosed
EP-2097079-A2 MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS Hunter-Fleming Limited (GB) 2009-09-09 EP disclosed
WO-2008065408-A2 MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS HUNTER-FLEMING LIMITED (GB) 2008-06-05 WO disclosed
EP-1848426-A2 TRICYCLIC CYTOPROTECTIVE COMPOUNDS Hunter-Fleming Limited (GB) 2007-10-31 EP disclosed
CN-1326853-C 4- (2-furoyl) aminopiperidines, intermediates for the synthesis thereof, process for the preparation thereof and use thereof as medicaments KYORIN SEIYAKU KK (JP) 2007-07-18 CN disclosed
EP-1221440-B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators OTSUKA PHARMA CO LTD (JP) 2007-04-25 EP disclosed
WO-2006082409-A2 TRICYCLIC CYTOPROTECTIVE COMPOUNDS HUNTER-FLEMING LIMITED (GB) 2006-08-10 WO disclosed
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0382185-A2 Carbostyril derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-08-16 EP disclosed
US-4707476-A TRANQUILIZERS CIBA-GEIGY CORPORATION (US) 1987-11-17 US disclosed
EP-0239129-A2 Hydroquinoline compounds, compositions containing same and processes for preparing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-09-30 EP disclosed
US-4492691-A TRANSQUILIZERS, SEDATIVES CIBA-GEIGY CORPORATION (US) 1985-01-08 US disclosed
EP-0030916-B1 AZATETRACYCLIC CARBONITRILES CIBA-GEIGY AG (CH) 1984-08-29 EP disclosed
EP-0030916-A1 Azatetracyclic carbonitriles CIBA-GEIGY AG (CH) 1981-06-24 EP disclosed
US-4263315-A TRANQUILLIZERS; SEDATIVES; ANTAGONIST FOR STIMULANTS CIBA-GEIGY CORPORATION (US) 1981-04-21 US disclosed
EP-0007450-A1 Azatetracyclic carbonitriles, their preparation, pharmaceutical compositions containing them and their application CIBA-GEIGY AG (CH) 1980-02-06 EP disclosed
US-3996373-A 2,3-Dihydro-1H-dibenz[e,g]isoindole compounds CIBA-GEIGY CORPORATION (US) 1976-12-07 US disclosed